Compounds > cycloheximide
Page last updated: 2024-08-17

cycloheximide and Cutaneous T-Cell Lymphoma

cycloheximide has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Einhorn, S; Erickson, S; Grandér, D; Gruber, A; Pisa, P; Sangfelt, O; Szeps, M; Xu, D1

Other Studies

1 other study(ies) available for cycloheximide and Cutaneous T-Cell Lymphoma

ArticleYear
Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
    Blood, 2000, Dec-15, Volume: 96, Issue:13

    Topics: Acute Disease; Antineoplastic Agents; Burkitt Lymphoma; Cell Cycle; Cycloheximide; Depression, Chemical; DNA Replication; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Induction; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Protein Synthesis Inhibitors; Recombinant Proteins; RNA; RNA, Messenger; RNA, Neoplasm; T-Lymphocytes; Telomerase; Transcription, Genetic; Tumor Cells, Cultured

2000